Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)

Name: Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)
Published: 2009
License: Public Domain

M.D. Anderson Cancer Center · 2009

ClinicalTrials.gov · Datasets · License: Public Domain · 2009

Open Source ↗

leukemia pediatrics

leukemia, pediatric cancer, blood and marrow transplantation, relapsed acute lymphoblastic leukemia, all, pediatrics, haploidentical nk cells, cyclophosphamide, cytoxan, neosar, epratuzumab, fludarabine

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 1010865
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.